PRESS RELEASE published on 01/24/2024 at 14:00, 2 years 5 months ago AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement AiCuris and the German Center for Infection Research (DZIF) have signed a collaboration and license option agreement to discover new active agents for the treatment and prophylaxis of infections of immunocompromised patients. The partnership aims to develop novel therapies for patients with high medical need. The financial details of the collaboration were not disclosed. For more information, visit www.dzif.de and www.aicuris.com. AiCuris German Center For Infection Research Collaboration License Option Agreement Immunocompromised Patients
PRESS RELEASE published on 09/28/2023 at 14:00, 2 years 8 months ago AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
PRESS RELEASE published on 08/23/2023 at 14:00, 2 years 10 months ago AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
PRESS RELEASE published on 07/06/2023 at 14:00, 2 years 11 months ago AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
PRESS RELEASE published on 04/04/2023 at 14:00, 3 years 2 months ago AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary
Published on 06/26/2026 at 14:05, 6 hours 7 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 6 hours 12 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 7 hours 12 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 7 hours 27 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 19:50, 22 minutes ago Name Change Completed for C Capital's Swiss Listed Entity, Ticker Symbol CCAP Goes Live
Published on 06/26/2026 at 19:10, 1 hour 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/26/2026 at 18:04, 2 hours 8 minutes ago Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application
Published on 06/26/2026 at 18:00, 2 hours 12 minutes ago PSP Swiss Property has sold the Richtipark in Wallisellen. The EBITDA guidance for the 2026 financial year has been increased.
Published on 06/26/2026 at 18:00, 2 hours 12 minutes ago VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
Published on 06/26/2026 at 07:00, 13 hours 12 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 07:30, 1 day 12 hours ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
